Trial
NCT00142051
Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Boston Children's Hospital
Collaborators
FDA Office of Orphan Products Development
Condition
Sickle Cell Disease
Intervention
nitric oxide
Why stopped
18 or 20 enrolled, stopped due to paucity of available participants
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-02-23